EPW
ABBV icon

Evolve Private Wealth’s AbbVie ABBV Stock Holding History

Evolve Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Sell
6,889
-7,330
-52% -$1.58M 0.11% 170
2026
Q1 		$3.09M Buy
14,219
+2,337
+20% +$518K 0.17% 114
2025
Q4 		$2.72M Buy
+11,882
New +$2.71M 0.16% 113

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Evolve Private Wealth's ABBV Position: Q2 2026 in Review

Evolve Private Wealth reduced its AbbVie (ABBV) stake by 52% in Q2 2026, selling an estimated $1.58M and leaving 6,889 shares worth $1.73M. The position accounts for 0.11% of the portfolio, ranked #170.

Evolve Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.09M in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evolve Private Wealth held 6,889 shares of AbbVie worth $1.73M as of Q2 2026.
  • Evolve Private Wealth sold 7,330 AbbVie shares in Q2 2026, an estimated $1.58M.
  • AbbVie made up 0.11% of Evolve Private Wealth's portfolio in Q2 2026, its #170 holding.
  • Evolve Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's AbbVie position peaked at $3.09M in Q1 2026.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.